Skip to main content

Table 3 Results of the multiple logistic regression model

From: Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries

 

BZD users

N = 423 (%)

BZD non-users

N = 2384 (%)

Adjusted

ORb

95% LCI

95% UCI

p-value

Country

 Croatia

136 (32.2)

244 (10.2)

1

   

 Serbia

144 (34.0)

316 (13.3)

1.11

0.79

1.56

0.543

 Spain

87 (20.6)

173 (7.3)

0.49

0.32

0.75

0.001

 Estonia

26 (6.1)

284 (11.9)

0.23

0.14

0.37

 < 0.001

 Bulgaria

16 (3.8)

481 (20.2)

0.08

0.04

0.14

 < 0.001

 Czech Republic

11 (2.6)

439 (18.4)

0.05

0.02

0.09

 < 0.001

 Turkey

3 (0.7)

447 (18.8)

0.01

0.00

0.03

 < 0.001

Gender

 Male

116 (27.4)

979 (41.1)

1

   

 Female

307 (72.6)

1405 (58.9)

1.58

1.19

2.1

0.002

Number of medicationsa

 < 10

372 (87.9)

2,268 (95.1)

1

   

 >  = 10

51 (12.1)

116 (4.9)

1.97

1.22

3.16

0.005

Depression

 Not present

324 (76.6)

2,224 (93.3)

1

   

 Present

99 (23.4)

160 (6.7)

1.95

1.29

2.95

0.002

Anxiety disorder

 Not present

297 (70.2)

2,275 (95.4)

1

   

 Present

126 (29.8)

109 (4.6)

4.26

2.86

6.38

 < 0.001

Sleeping problem

 Not present

178 (42.1)

2,074 (87.0)

1

   

 Present

245 (57.9)

310 (13.0)

4.47

3.38

5.92

 < 0.001

Repetitive anxious complaints

 Not exhibited

288 (68.1)

1,972 (82.7)

1

   

 Exhibited

135 (31.9)

412 (17.3)

1.77

1.29

2.42

 < 0.001

Loss of appetite

 No

377 (89.1)

2,159 (90.6)

1

   

 Yes

46 (10.9)

225 (9.4)

0.6

0.38

0.94

0.027

Syncope

 No

384 (90.8)

2,310 (96.9)

1

   

 Yes

39 (9.2)

74 (3.1)

1.78

1.03

3.06

0.038

  1. aNumber of medications does not include BZDs
  2. bAdjusted for all variables presented in the Table 3